HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells (Q39819780)

14 September 2017

title

HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells (English)

1 reference

14 September 2017

1 reference

Alexander Greenhough

0 references

Ann C Williams

0 references

Amy E Moore

1 reference

14 September 2017

Heather R Roberts

1 reference

14 September 2017

Diane J Hicks

1 reference

14 September 2017

Helena A Patsos

1 reference

14 September 2017

Christos Paraskeva

1 reference

14 September 2017

language of work or name

English

0 references

publication date

28 July 2009

1 reference

14 September 2017

1 reference

14 September 2017

1 reference

14 September 2017

1 reference

14 September 2017

page(s)

1796-1804

1 reference

Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

COX-2: a molecular target for colorectal cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Prostaglandin E2 increases growth and motility of colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Functional expression of HGF and its receptor in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Invasive growth: a MET-driven genetic programme for cancer and stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Met, metastasis, motility and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Drug development of MET inhibitors: targeting oncogene addiction and expedience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Hepatocyte growth factor installs a survival platform for colorectal cancer cell invasive growth and overcomes p38 MAPK-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Insulin regulates the activity of forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

Enhanced angiogenesis and improvement of neuropathy by cotransfection of human hepatocyte growth factor and prostacyclin synthase gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

The MET oncogene drives a genetic programme linking cancer to haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

A positive feedback loop between hepatocyte growth factor receptor and β-catenin sustains colorectal cancer cell invasive growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP183

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGP183

1 reference

release_sluzcbfjjrbz5dfloyb2ttpl4u

14 September 2017

Fatcat ID

0 references

1 reference